navigation
Deutsch English Home Service Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie

Microscopy and stains in histology
Immune sera, Antibodies
Markers and conjugates
Tissue preparation
Immuno-staining, other ligand detection
Selection of staining protocols
Specificity, control reactions
Reagents, solutions
Laboratory methods
Acronyms
References
Applied cell labeling  

nav_footer
nav_dekoline
HomeCell-MarkerApplied cell labeling → Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis




Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis

Wolf D. Kuhlmann, R. Krischan, W. Kunz, T. M. Guenthner, F. Oesch

Institute of Nuclear Medicine (W.D.K.) and Institute of Biochemistry (R.K. and W.K.)
of the German Cancer Research Center, D-6900 Heidelberg
Institute of Pharmacology (T.M.G. and F.O.), University of Mainz, D-6500 Mainz, FRG



Treatment of rats with N-nitrosomorpholine (NNM) for 7 weeks led to a focal increase in liver microsomal epoxide hydrolase (EH) as early as 2 weeks after withdrawal of the carcinogen. This treatment also leads to hyperplastic nodules and liver tumors, but much later. At the same early time point, ATPase activity was decreased in the same islands. Most of these areas already had increased ã-glutamyltranspeptidase activity. The increase in EH at this early time point was more distinct than the decrease in ATPase which has thus far been considered a suitable marker of the earliest stages in hepatocarcinogenesis. The focal increase in EH was also observed in all benign hepatomas, but not in any of the hepatocellular carcinomas investigated so far.

download